Literature DB >> 19822353

Impaired secretion of carboxyl-terminal truncated factor VII due to an F7 nonsense mutation associated with FVII deficiency.

Ryoko Tanaka1, Daisuke Nakashima, Atsuo Suzuki, Yuhri Miyawaki, Yuta Fujimori, Takayuki Yamada, Akira Takagi, Takashi Murate, Koji Yamamoto, Akira Katsumi, Tadashi Matsushita, Tomoki Naoe, Tetsuhito Kojima.   

Abstract

INTRODUCTION: Factor VII (FVII) is a vitamin K-dependent glycoprotein secreted into the blood circulation from hepatic cells. We investigated the molecular basis of the congenital FVII deficiency found in a Japanese patient.
MATERIALS AND METHODS: We analyzed the F7 gene of the patient, who was diagnosed with a FVII deficiency at pregnancy. We expressed a carboxyl-terminal truncated FVII (Arg462X FVII) corresponding to the identified mutation in CHO-K1 cells. To study roles of the carboxyl-terminus in the secretion of FVII, we also expressed a series of recombinant FVIIs deleted of limited numbers of carboxyl-terminal amino acids (462Arg-466Pro).
RESULTS: We identified a nonsense mutation (c.1384C>T: p.Arg462X) in F7, leading to a lack of five amino acids in the carboxyl-terminus. In expression experiments, Arg462X FVII was undetectable not only by Western blotting, but also by ELISA. A Western blot analysis of the truncated FVIIs revealed that all mutants were expressed in the cells the same as the wild type, but were secreted into the culture medium in lesser amounts than the wild type depending on the length of the deletion, which was confirmed by ELISA. Arg462X FVII did not colocalize with the Golgi on immunofluorescence staining, suggesting that it might be retained in the ER and degraded in the cell.
CONCLUSION: The carboxyl-terminal amino acids of FVII play an important role in its secretion, and the p.Arg462X mutation was likely to have caused the FVII deficiency in this patient. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822353     DOI: 10.1016/j.thromres.2009.09.014

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency.

Authors:  Alessio Branchini; Lara Rizzotto; Guglielmo Mariani; Mariasanta Napolitano; Mario Lapecorella; Muriel Giansily-Blaizot; Rosella Mari; Alessandro Canella; Mirko Pinotti; Francesco Bernardi
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

2.  Replacement of the Y450 (c234) phenyl ring in the carboxyl-terminal region of coagulation factor IX causes pleiotropic effects on secretion and enzyme activity.

Authors:  Alessio Branchini; Matteo Campioni; Maria Gabriella Mazzucconi; Francesca Biondo; Rosella Mari; Maria Patrizia Bicocchi; Francesco Bernardi; Mirko Pinotti
Journal:  FEBS Lett       Date:  2013-08-27       Impact factor: 4.124

3.  Functional and Molecular Characterization of C91S Mutation in the Second Epidermal Growth Factor-Like Domain of Factor VII.

Authors:  Amir Mashayekhi; Shirin Shahbazi; Mirdavood Omrani
Journal:  Iran J Biotechnol       Date:  2018-04-18       Impact factor: 1.671

4.  Novel factor VII gene mutations in six families with hereditary coagulation factor VII deficiency.

Authors:  Xiaoyu Zhang; Shuwen Wang; Shaoqiu Leng; Qi Feng; Yanqi Zhang; Shuqian Xu; Lei Zhang; Xinsheng Zhang; Yunhai Fang; Jun Peng; Zi Sheng
Journal:  J Clin Lab Anal       Date:  2021-08-02       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.